Wayfinding Financial, LLC

Position in MRK — Merck & Co., Inc.

CIK 1898131 LYNNWOOD, WA

Position in MRK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$300,304

+$22,795 QoQ

Shares Held

2,337

+1.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#3,169

of 3,769 holders

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wayfinding Financial, LLC holds $5,872,950 across 8 Drug Manufacturers - General names. MRK ranks #7 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	6,634	$1,684,836
2	ABBV	AbbVie Inc.	5,660	$1,424,282
3	LLY	ELI LILLY & Co	933	$1,119,068
4	GILD	Gilead Sciences, Inc.	3,101	$391,780
5	AMGN	Amgen Inc	973	$352,342
6	NVS	Novartis AG	2,153	$337,418
7	MRK	Merck & Co., Inc. This page	2,337	$300,304
8	BMY	Bristol Myers Squibb Co	4,563	$262,920

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$300,304	2,337	+1.3%	Shares	Sole	2026-08-13
2026-03-31	$277,509	2,307	-2.2%	Shares	Sole	2026-05-12
2025-12-31	$248,413	2,360	-44.2%	Shares	Sole	2026-02-12
2025-03-31	$379,774	4,231	-1.3%	Shares	Sole	2025-04-29
2024-12-31	$426,470	4,287	+3.0%	Shares	Sole	2025-02-11
2024-06-30	$515,379	4,163	-21.7%	Shares	Sole	2024-08-09
2024-03-31	$701,842	5,319	+8.9%	Shares	Sole	2024-05-09
2023-12-31	$532,453	4,884	-5.7%	Shares	Sole	2024-01-10
2023-09-30	$533,075	5,178	-4.4%	Shares	Sole	2023-11-02
2023-06-30	$625,067	5,417	+7.1%	Shares	Sole	2023-07-31
2023-03-31	$538,333	5,060	+8.2%	Shares	Sole	2023-05-05
2022-12-31	$376	4,676	-5.5%	Shares	Sole	2023-02-10
2022-09-30	$426,207	4,949	+1.7%	Shares	Sole	2022-11-09
2022-06-30	$443,450	4,864	+0.4%	Shares	Sole	2022-08-09
2022-03-31	$397,532	4,845	+3.6%	Shares	Sole	2022-05-09
2021-12-31	$358,368	4,676	—	Shares	Sole	2022-01-28
No filing history on record for this holder in this stock.